- Home
- AKAN vs ONCO Comparison
AKAN vs ONCO Comparison
Compare AKAN & ONCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKAN
- ONCO
- Stock Information
- Founded
- AKAN 2021
- ONCO 2018
- Country
- AKAN Canada
- ONCO United States
- Employees
- AKAN N/A
- ONCO N/A
- Industry
- AKAN Medicinal Chemicals and Botanical Products
- ONCO Biotechnology: Pharmaceutical Preparations
- Sector
- AKAN Health Care
- ONCO Health Care
- Exchange
- AKAN Nasdaq
- ONCO Nasdaq
- Market Cap
- AKAN 1.7M
- ONCO 1.8M
- IPO Year
- AKAN 2022
- ONCO 2022
- Fundamental
- Price
- AKAN $1.20
- ONCO $0.08
- Analyst Decision
- AKAN
- ONCO
- Analyst Count
- AKAN 0
- ONCO 0
- Target Price
- AKAN N/A
- ONCO N/A
- AVG Volume (30 Days)
- AKAN 37.6K
- ONCO 45.0M
- Earning Date
- AKAN 05-27-2025
- ONCO 05-27-2025
- Dividend Yield
- AKAN N/A
- ONCO N/A
- EPS Growth
- AKAN N/A
- ONCO N/A
- EPS
- AKAN N/A
- ONCO N/A
- Revenue
- AKAN $836,664.00
- ONCO $1,870,605.00
- Revenue This Year
- AKAN N/A
- ONCO N/A
- Revenue Next Year
- AKAN N/A
- ONCO N/A
- P/E Ratio
- AKAN N/A
- ONCO N/A
- Revenue Growth
- AKAN 97.47
- ONCO N/A
- 52 Week Low
- AKAN $0.93
- ONCO $0.05
- 52 Week High
- AKAN $47.52
- ONCO $21.40
- Technical
- Relative Strength Index (RSI)
- AKAN 47.92
- ONCO 49.99
- Support Level
- AKAN $1.15
- ONCO $0.07
- Resistance Level
- AKAN $1.25
- ONCO $0.18
- Average True Range (ATR)
- AKAN 0.07
- ONCO 0.02
- MACD
- AKAN 0.01
- ONCO 0.01
- Stochastic Oscillator
- AKAN 30.82
- ONCO 21.48
About AKAN Akanda Corp.
Akanda Corp is a cannabis cultivation, manufacturing, and distribution company. The Company has three reportable segments: Cultivation, Distribution, and Corporate. Cultivating activities comprise the cultivation segment made up of the medical cannabis cultivation operations at RPK/Holigen in Portugal, and medical cannabis cultivation activities. Distributing activities relate to the distribution of medical cannabis by Canmart Ltd in the United Kingdom. Corporate activities entail head office costs and other general corporate expenses related to the administration of the broader group.
About ONCO Onconetix Inc.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.